已收盤 02-06 16:00:00 美东时间
+0.060
+0.16%
UPDATE 2-Catering group Compass' shares fall as AI concerns overshadow revenue beat Updates throughout with details on AI disruption, shares and analyst comment Shares hit three-year low despite revenue beat Concerns over AI disruption hurt investor sentiment Compass reaffirms fiscal 2026 guidance B
02-05 15:21
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
Morgan Stanley analyst Toni Kaplan maintains Aramark (NYSE:ARMK) with a Equal-Weight and raises the price target from $43 to $44.
2025-12-17 21:47
Venu Holding Corporation (VENU) has signed a transformative Operator Agreement with Live Nation, marking a significant step in its national expansion. Under the deal, Live Nation becomes the exclusive operator and booking agent for VENU's 20,000-capacity Sunset Amphitheater in McKinney, Texas. This partnership enhances VENU's growth trajectory, profitability, and financial visibility, leveraging Live Nation's global booking power and artist relat...
2025-12-12 15:13
今日重点评级关注:富国银行:维持Annexon"超配"评级,目标价从14美元升至27美元;瑞穗:上调Relmada Therapeutics评级至"跑赢大市",目标价从1美元升至10美元
2025-11-20 10:28
今日重点评级关注:Oppenheimer:维持Olema Pharmaceuticals"跑赢大市"评级,目标价从22美元升至45美元;Bernstein:维持Atlassian"跑赢大市"评级,目标价从290美元升至304美元
2025-11-19 11:01
Baird analyst Andrew Wittmann maintains Aramark (NYSE:ARMK) with a Outperform and lowers the price target from $47 to $46.
2025-11-19 00:01
Aramark's stock (ARMK) fell after reporting lower fourth-quarter FY25 earnings, with revenue missing analyst estimates.
2025-11-17 22:55